1. Home/
  2. Compounds/
  3. navitoclax:sorafenib (1:1 mol/mol)

navitoclax:sorafenib (1:1 mol/mol)


SourcesNames Used
CTRPv2navitoclax:sorafenib (1:1 mol/mol)
PharmacoGx navitoclax:sorafenib (1:1 mol/mol)

Cell lines tested with navitoclax:sorafenib (1:1 mol/mol)

835 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
DU-145 prostate CTRPv22
AsPC-1 pancreas CTRPv22
NCI-H1869 lung CTRPv22
CCF-STTG1 central nervous system CTRPv22
OAW-28 ovary CTRPv22
HeLa cervix CTRPv22
LOXIMVI haematopoietic and lymphoid tissue CTRPv22
NCI-H520 lung CTRPv22
MKN74 stomach CTRPv22
Download CSV

Tissues tested with navitoclax:sorafenib (1:1 mol/mol)

25 tissues have been tested with this compound, using data from 1 dataset(s).
haematopoietic and lymphoid tissueCTRPv2154
central nervous systemCTRPv247
large intestineCTRPv244
upper aerodigestive tractCTRPv232
Download CSV
Download Data as CSV

Top molecular features associated with response to navitoclax:sorafenib (1:1 mol/mol)

Feature TypeStandardized
Nominal ANOVA
mRNA ARHGAP33 CTRPv2 AAC 0.33 2e-20
mRNA TUBA1A CTRPv2 AAC 0.3 2e-14
mRNA RP11-729L2.2 CTRPv2 AAC 0.29 2e-14
mRNA SMAD4 CTRPv2 AAC 0.28 2e-14
mRNA GOLGA8M CTRPv2 AAC 0.26 2e-14
mRNA CELF4 CTRPv2 AAC 0.28 2e-14
mRNA PRR36 CTRPv2 AAC 0.28 6e-14
mRNA HDHD2 CTRPv2 AAC 0.28 7e-14
mRNA TIFAB CTRPv2 AAC 0.25 8e-14
mRNA CRMP1 CTRPv2 AAC 0.3 9e-14
Download CSV